The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts

Transplantation

Volumn 61, Issue 5, 1996, Pages 804-811

  Binder, Jochen ^a,b   Lehmann, Manfred ^c   Graser, Elmara ^d   Hancock, Wayne W ^e   Watschinger, Bruno ^a   Onodera, Kazuhiko ^a   Sayegh, Mohamed H ^a   Volk, Hans Dieter ^d   Kupiec Weglinski, Jerzy W ^a,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; OKT 4;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY BLOOD FLOW; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; CELLS, CULTURED; CYTOKINES; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOGLOBULIN G; ISOANTIBODIES; MALE; RATS; RATS, INBRED BN; RATS, INBRED LEW; RATS, INBRED WF; RNA, MESSENGER; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029967728     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199603150-00022     Document Type: Article

References (45)

1. Sanfilippo FP, Vaughn WK, Peters TG, et al. Factors affecting the waiting time of cadaveric kidney transplant candidates in the United States. JAMA 1992; 267: 247.
2. Di Stefano R, Kupiec-Weglinski JW, Uhteg LC, et al. Modulation of accelerated rat cardiac allograft rejection by cyclosporine and ART-18. Transplant Proc 1988; 20: 217.
3. + cells in the sensitization and effector phases of accelerated graft rejection. Transplantation 1991; 51: 226.
4. Hancock WW, Di Stefano R, Braun P, Schweizer R, Tilney NL, Kupiec-Weglinski JW. CsA and anti-interleukin 2-receptor monoclonal antibody therapy in rats suppress accelerated rejection of cardiac allografts through different effector mechanisms. Transplantation 1990; 48: 416.
5. Kupiec-Weglinski JW, Sablinski T, Hancock WW, et al. Modulation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy. Transplantation 1991; 51: 300.
6. Sablinski T, Hancock WW, Tilney NL, Kupiec-Weglinski JW. CD4 monoclonal antibodies in organ transplantation - a review of progress. Transplantation 1991; 52: 579.
7. Wood KJ, Pearson TC, Darby C, Morris PJ. CD4: a potential target molecule for immunosuppressive therapy and tolerance induction. Transplant Rev 1991; 5: 150.
8. Binder J, Kupiec-Weglinski JW. CD4 targeted therapy in organ graft recipients. Transplant Sci 1993; 3: 210.
9. Morel P, Vincent C, Cordier G, Panaye G, Carosella E, Revillard JP. Anti-CD4 monoclonal antibody administration in renal transplanted patients. Clin Immunol Immunopathol 1990; 56: 311.
10. Reinke P, Volk HD, Miller H. Anti-CD4 therapy of acute rejection in long-term renal allograft recipients. Lancet 1991; 338: 702.
11. Burkhardt K, Charlton B, Mandel TE. An increase in the survival of murine H-2-mismatched cultured fetal pancreas allografts using depleting or nondepleting anti-CD4 monoclonal antibodies, and a further increase with the addition of cyclosporine. Transplantation 1989; 47: 771.
12. Qin SX, Wise M, Cobbold SP, Waldmann H. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur J Immunol 1990; 20: 2737.
13. Darby CA, Bushell A, Morris PJ, Wood KJ. Nondepleting anti-CD4 antibodies in transplantation. Evidence that modulation is far less effective than prolonged CD4 blockade. Transplantation 1994; 57: 1419.
14. + T cells. Transplantation 1992; 54: 483.
15. + cells. J Immunol 1988; 140: 713.
16. Sayegh MH, Kut JP, Milford EL. Anti-CD4 monoclonal antibody effects cellular hyporesponsiveness and prolongs renal allograft survival in the rat. Hum Immunol 1989; 26: 131.
17. + T cells in vivo: differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts. J Immunol 1992; 148: 1308.
18. + T cell subset at the time of antigenic challenge for induction of prolonged vascularized allograft survival. Transplantation 1992; 53: 219.
19. + cells modulate accelerated rejection of cardiac allografts in sensitized rats by different mechanisms. Transplantation 1992; 54: 292.
20. Kupiec-Weglinski JW, Wasowska B, Papp I, et al. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines. J Immunol 1993; 151: 5053.
21. Lehmann M, Sternkopf F, Metz F, Volk HD. Induction of long-term survival of rat skin allografts by a novel, highly efficient anti-CD4 monoclonal antibody. Transplantation 1992; 54: 959.
22. Siegling A, Lehmann M, Riedel H, Volk HD. A nondepleting anti-rat CD4 monoclonal antibody that suppresses T helper 1-like but not T helper 2-like intragraft lymphokine secretion induces long-term survival of renal allografts. Transplantation 1994; 57: 464.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156.
24. Siegling A, Lehmann M, Platzer C, Emmrich F, Volk HD. A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats. J Immunol Meth 1994; 177: 23.
25. Baldwin WM III, Rhoton K, Sanfilippo F. IgM and IgG alloantibody production by splenocytes and deposition in rat renal allografts are decreased by donor-specific blood transfusion. Transplantation 1991; 51: 481.
26. Schmidbauer G, Hancock WW, Wasowska B, Badger AM, Kupiec-Weglinski JW. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear/ endothelial cell activation, cytokine production, and cell adhesion. Transplantation 1994; 57: 933.
27. Heidecke CD, Hancock WW, Jakobs F, et al. α/β-T cell receptor-directed therapy in rat cardiac allograft recipients: treatment prior to alloantigen exposure prevents sensitization and abrogates accelerated rejection. Transplantation 1995; 59: 78.
28. Charlton B, Auchincloss H, Fathman CG. Mechanisms of transplantation tolerance. Annu Rev Immunol 1994; 12: 707.
29. Shizuru JA, Seydel KB, Flavin TF, et al. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Transplantation 1990; 50: 366.
30. Wasowska B, Wieder KJ, Hancock WW, et al. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients. Transplant Proc 1995; 27: 423.
31. Binder J, Graser E, Hancock WW, et al. Downregulation of intragraft IFN-γ expression correlates with increased IgG1 alloantibody response following intrathymic immunomodulation of sensitized rat recipients. Transplantation 1995; 60: 1516.
32. Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the IL-2 pathway. J Exp Med 1991; 173: 79.
33. Wasowska B, Wieder KJ, Hancock WW, et al. Cytokine and alloantibody networks in long-term cardiac allografts in rat recipients treated with rapamycin. J Immunol 1996; 156: 395.
34. Lowry RP. The relationship of IL-4, IL-10 and other cytokines to transplantation tolerance. Transplant Sci 1993; 3: 104.
35. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989; 46: 111.
36. Kopf M, Le Gros G, Bachmann M, Lamers MC, Blueethmann H, Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993; 362: 245.
37. Nickerson P, Steurer W, Steiger J, Zheng X, Steele AW, Strom TB. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 1994; 6: 757.
38. Lee ML, Wogensen L, Shizuru J, Oldstone MBA, Sarvetnick N. Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J Clin Invest 1994; 93: 1332.
39. Zheng X, Steele AW, Nickerson PW, et al. Administration of non-cytolitic IL-10/Fc in murine models of lipopolisaccharide-induced septic shock and allogeneic islet transplantation. J Immunol 1995; 154: 5590.
40. Steiger J, Nickerson PW, Steurer W, Moscovitch-Lopatin M, Strom TB. IL-2 knockout recipient mice reject islet cell allografts. J Immunol 1995; 155: 489.
41. Wray DW, Baldwin WM III, Sanfilippo F. Different patterns of sensitization following renal allograft rejection in an inbred rat strain combination. Transplantation 1993; 55: 1132.
42. Der Balian GP, Slack J, Clevinger BL, Bazin H, Davie JM. Subclass restriction of murine antibodies. J Exp Med 1980; 152: 209.
43. Finkelman FD, Holmes J, Katona IM, et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990; 8: 303.
44. Bossie A, Vitetta ES. Interferon-γ enhances secretion of IgG2a-committed LPS-stimulated murine B cells: implications for the role of IFN-γ in class switching. Cell Immunol 1991; 135: 95.
45. + T cells in the presence of nondepleting monoclonal antibody to CD4 induces a Th2-type response in vitro. J Exp Med 1995; 182: 5.